271 related articles for article (PubMed ID: 8406837)
1. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.
Michalski J; Galen JE; Fasano A; Kaper JB
Infect Immun; 1993 Oct; 61(10):4462-8. PubMed ID: 8406837
[TBL] [Abstract][Full Text] [Related]
2. Distribution of genes encoding cholera toxin, zonula occludens toxin, accessory cholera toxin, and El Tor hemolysin in Vibrio cholerae of diverse origins.
Kurazono H; Pal A; Bag PK; Nair GB; Karasawa T; Mihara T; Takeda Y
Microb Pathog; 1995 Mar; 18(3):231-5. PubMed ID: 7565017
[TBL] [Abstract][Full Text] [Related]
3. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains.
Olivier V; Haines GK; Tan Y; Satchell KJ
Infect Immun; 2007 Oct; 75(10):5035-42. PubMed ID: 17698573
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
Tacket CO; Losonsky G; Nataro JP; Cryz SJ; Edelman R; Fasano A; Michalski J; Kaper JB; Levine MM
J Infect Dis; 1993 Dec; 168(6):1536-40. PubMed ID: 8245542
[TBL] [Abstract][Full Text] [Related]
5. Novel Cholera Toxin Variant and ToxT Regulon in Environmental
Neogi SB; Chowdhury N; Awasthi SP; Asakura M; Okuno K; Mahmud ZH; Islam MS; Hinenoya A; Nair GB; Yamasaki S
Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30446560
[TBL] [Abstract][Full Text] [Related]
6. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
Häse CC; Thai LS; Boesman-Finkelstein M; Mar VL; Burnette WN; Kaslow HR; Stevens LA; Moss J; Finkelstein RA
Infect Immun; 1994 Aug; 62(8):3051-7. PubMed ID: 8039872
[TBL] [Abstract][Full Text] [Related]
8. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
[TBL] [Abstract][Full Text] [Related]
9. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains.
Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T
Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382
[TBL] [Abstract][Full Text] [Related]
10. Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage.
Faruque SM; Tam VC; Chowdhury N; Diraphat P; Dziejman M; Heidelberg JF; Clemens JD; Mekalanos JJ; Nair GB
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5151-6. PubMed ID: 17360342
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of Vibrio cholerae O1, O139, non-O1, and non-O139 strains: clonal relationships between clinical and environmental isolates.
Singh DV; Matte MH; Matte GR; Jiang S; Sabeena F; Shukla BN; Sanyal SC; Huq A; Colwell RR
Appl Environ Microbiol; 2001 Feb; 67(2):910-21. PubMed ID: 11157262
[TBL] [Abstract][Full Text] [Related]
12. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
13. Heterologous antigen expression in Vibrio cholerae vector strains.
Butterton JR; Beattie DT; Gardel CL; Carroll PA; Hyman T; Killeen KP; Mekalanos JJ; Calderwood SB
Infect Immun; 1995 Jul; 63(7):2689-96. PubMed ID: 7790086
[TBL] [Abstract][Full Text] [Related]
14. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh.
Nair GB; Faruque SM; Bhuiyan NA; Kamruzzaman M; Siddique AK; Sack DA
J Clin Microbiol; 2002 Sep; 40(9):3296-9. PubMed ID: 12202569
[TBL] [Abstract][Full Text] [Related]
15. Genesis of variants of Vibrio cholerae O1 biotype El Tor: role of the CTXphi array and its position in the genome.
Nandi S; Maiti D; Saha A; Bhadra RK
Microbiology (Reading); 2003 Jan; 149(Pt 1):89-97. PubMed ID: 12576583
[TBL] [Abstract][Full Text] [Related]
16. El Tor Biotype
Mamantopoulos M; Frising UC; Asaoka T; van Loo G; Lamkanfi M; Wullaert A
Front Immunol; 2019; 10():2463. PubMed ID: 31736941
[No Abstract] [Full Text] [Related]
17. Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh.
Faruque SM; Ahmed KM; Abdul Alim AR; Qadri F; Siddique AK; Albert MJ
J Clin Microbiol; 1997 Mar; 35(3):624-30. PubMed ID: 9041401
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and genotypic characterization of Vibrio cholerae isolates from a recent cholera outbreak in Senegal: comparison with isolates from Guinea-Bissau.
Aidara A; Koblavi S; Boye CS; Raphenon G; Gassama A; Grimont F; Grimont PA
Am J Trop Med Hyg; 1998 Feb; 58(2):163-7. PubMed ID: 9502599
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Vibrio cholerae O1 classical biotype in 2012 in Iran.
Bakhshi B; Boustanshenas M; Mahmoudi-aznaveh A
Lett Appl Microbiol; 2014 Feb; 58(2):145-9. PubMed ID: 24117836
[TBL] [Abstract][Full Text] [Related]
20. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.
Waldor MK; Mekalanos JJ
J Infect Dis; 1994 Aug; 170(2):278-83. PubMed ID: 8035010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
